Table 1.
Clinically localized, biopsy Gleason score ≥ 7 and no significant comorbidities (N = 3959) | T1b-T2b N0M0, biopsy Gleason score ≤ 7 and PSA ≤ 15 ng/ml (N = 3536) | T1c PCa (N = 2330) | |
---|---|---|---|
Mean Age (range) | 61 (36–80) | 61 (36–80) | 60 (36–78) |
Race (% White) | 3735 (95%) | 3336 (95%) | 2168 (93%) |
Median PSA (range) | 5.6 (0.0–98.0) | 5.4 (0.0–15.0) | 5.5 (0.0–66.0) |
Biopsy Gleason > 6 | 694 (18%) | 596 (17%) | 415 (18%) |